Anti-Interleukin-8 (Anti-IL-8) for Patients With COVID-19
Clinical trial NCT04347226 · TERMINATED
Trial details
- NCT number
- NCT04347226
- Sponsor
- Columbia University
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-04-16
- Primary completion
- 2021-03-01
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.